TARGETED CANCER CHEMOTHERAPY: DEVELOPING NEXTGEN ANTIBODY-DRUG CONJUGATES
In today's presentation I will give an overview to developing NextGen ADCs. We will discuss everything from the beginning stages of development to the varying ADC combination therapies available